Literature DB >> 15831468

The phosphatidylinositol 3-phosphate phosphatase myotubularin- related protein 6 (MTMR6) is a negative regulator of the Ca2+-activated K+ channel KCa3.1.

Shekhar Srivastava1, Zhai Li, Lin Lin, GongXin Liu, Kyung Ko, William A Coetzee, Edward Y Skolnik.   

Abstract

Myotubularins (MTMs) belong to a large subfamily of phosphatases that dephosphorylate the 3' position of phosphatidylinositol 3-phosphate [PI(3)P] and PI(3,5)P(2). MTM1 is mutated in X-linked myotubular myopathy, and MTMR2 and MTMR13 are mutated in Charcot-Marie-Tooth syndrome. However, little is known about the general mechanism(s) whereby MTMs are regulated or the specific biological processes regulated by the different MTMs. We identified a Ca(2+)-activated K channel, K(Ca)3.1 (also known as KCa4, IKCa1, hIK1, or SK4), that specifically interacts with the MTMR6 subfamily of MTMs via coiled coil (CC) domains on both proteins. Overexpression of MTMR6 inhibited K(Ca)3.1 channel activity, and this inhibition required MTMR6's CC and phosphatase domains. This inhibition is specific; MTM1, a closely related MTM, did not inhibit K(Ca)3.1. However, a chimeric MTM1 in which the MTM1 CC domain was swapped for the MTMR6 CC domain inhibited K(Ca)3.1, indicating that MTM CC domains are sufficient to confer target specificity. K(Ca)3.1 was also inhibited by the PI(3) kinase inhibitors LY294002 and wortmannin, and this inhibition was rescued by the addition of PI(3)P, but not other phosphoinositides, to the patch pipette solution. PI(3)P also rescued the inhibition of K(Ca)3.1 by MTMR6 overexpression. These data, when taken together, indicate that K(Ca)3.1 is regulated by PI(3)P and that MTMR6 inhibits K(Ca)3.1 by dephosphorylating the 3' position of PI(3)P, possibly leading to decreased PI(3)P in lipid microdomains adjacent to K(Ca)3.1. K(Ca)3.1 plays important roles in controlling proliferation by T cells, vascular smooth muscle cells, and some cancer cell lines. Thus, our findings not only provide unique insights into the regulation of K(Ca)3.1 channel activity but also raise the possibility that MTMs play important roles in the negative regulation of T cells and in conditions associated with pathological cell proliferation, such as cancer and atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15831468      PMCID: PMC1084293          DOI: 10.1128/MCB.25.9.3630-3638.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  41 in total

Review 1.  The Ca2+-activated K+ channel of intermediate conductance:a possible target for immune suppression.

Authors:  B S Jensen; M Hertz; P Christophersen; L S Madsen
Journal:  Expert Opin Ther Targets       Date:  2002-12       Impact factor: 6.902

2.  Disease-related myotubularins function in endocytic traffic in Caenorhabditis elegans.

Authors:  Hope Dang; Zhai Li; Edward Y Skolnik; Hanna Fares
Journal:  Mol Biol Cell       Date:  2003-10-17       Impact factor: 4.138

3.  Trafficking of the Ca2+-activated K+ channel, hIK1, is dependent upon a C-terminal leucine zipper.

Authors:  Colin A Syme; Kirk L Hamilton; Heather M Jones; Aaron C Gerlach; LeeAnn Giltinan; Glenn D Papworth; Simon C Watkins; Neil A Bradbury; Daniel C Devor
Journal:  J Biol Chem       Date:  2002-12-18       Impact factor: 5.157

4.  Unexpected down-regulation of the hIK1 Ca2+-activated K+ channel by its opener 1-ethyl-2-benzimidazolinone in HaCaT keratinocytes. Inverse effects on cell growth and proliferation.

Authors:  Heidi Koegel; Susanne Kaesler; Ralf Burgstahler; Sabine Werner; Christian Alzheimer
Journal:  J Biol Chem       Date:  2002-11-05       Impact factor: 5.157

5.  Regulation of myotubularin-related (MTMR)2 phosphatidylinositol phosphatase by MTMR5, a catalytically inactive phosphatase.

Authors:  Soo-A Kim; Panayiotis O Vacratsis; Ron Firestein; Michael L Cleary; Jack E Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-31       Impact factor: 11.205

6.  Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis.

Authors:  Ralf Köhler; Heike Wulff; Ines Eichler; Marlene Kneifel; Daniel Neumann; Andrea Knorr; Ivica Grgic; Doris Kämpfe; Han Si; Judith Wibawa; Robert Real; Klaus Borner; Susanne Brakemeier; Hans-Dieter Orzechowski; Hans-Peter Reusch; Martin Paul; K George Chandy; Joachim Hoyer
Journal:  Circulation       Date:  2003-08-25       Impact factor: 29.690

Review 7.  Potassium channels as therapeutic targets for autoimmune disorders.

Authors:  Heike Wulff; Christine Beeton; K George Chandy
Journal:  Curr Opin Drug Discov Devel       Date:  2003-09

8.  Characterization of myotubularin-related protein 7 and its binding partner, myotubularin-related protein 9.

Authors:  Yasuhiro Mochizuki; Philip W Majerus
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-30       Impact factor: 11.205

9.  Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15.

Authors:  Jan Senderek; Carsten Bergmann; Susanne Weber; Uwe-Peter Ketelsen; Hubert Schorle; Sabine Rudnik-Schöneborn; Reinhard Büttner; Eckhard Buchheim; Klaus Zerres
Journal:  Hum Mol Genet       Date:  2003-02-01       Impact factor: 6.150

Review 10.  Myotubularins, a large disease-associated family of cooperating catalytically active and inactive phosphoinositides phosphatases.

Authors:  Jocelyn Laporte; Florence Bedez; Alessandra Bolino; Jean-Louis Mandel
Journal:  Hum Mol Genet       Date:  2003-08-12       Impact factor: 6.150

View more
  49 in total

1.  Wnt signalling requires MTM-6 and MTM-9 myotubularin lipid-phosphatase function in Wnt-producing cells.

Authors:  Marie Silhankova; Fillip Port; Martin Harterink; Konrad Basler; Hendrik C Korswagen
Journal:  EMBO J       Date:  2010-11-12       Impact factor: 11.598

2.  Phosphatidylinositol-3-kinase C2β and TRIM27 function to positively and negatively regulate IgE receptor activation of mast cells.

Authors:  Shekhar Srivastava; Xinjiang Cai; Zhai Li; Yi Sun; Edward Y Skolnik
Journal:  Mol Cell Biol       Date:  2012-05-29       Impact factor: 4.272

3.  Phosphatidylinositol-3 phosphatase myotubularin-related protein 6 negatively regulates CD4 T cells.

Authors:  Shekhar Srivastava; Kyung Ko; Papiya Choudhury; Zhai Li; Amanda K Johnson; Vivek Nadkarni; Derya Unutmaz; William A Coetzee; Edward Y Skolnik
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

4.  An NH2-terminal multi-basic RKR motif is required for the ATP-dependent regulation of hIK1.

Authors:  Heather M Jones; Mark A Bailey; Catherine J Baty; Gordon G Macgregor; Colin A Syme; Kirk L Hamilton; Daniel C Devor
Journal:  Channels (Austin)       Date:  2007-02-12       Impact factor: 2.581

5.  Cardiac ATP-sensitive K+ channel associates with the glycolytic enzyme complex.

Authors:  Miyoun Hong; Eirini Kefaloyianni; Li Bao; Brian Malester; Diane Delaroche; Thomas A Neubert; William A Coetzee
Journal:  FASEB J       Date:  2011-04-11       Impact factor: 5.191

6.  Phosphatidylinositol 3-phosphate indirectly activates KCa3.1 via 14 amino acids in the carboxy terminus of KCa3.1.

Authors:  Shekhar Srivastava; Papiya Choudhury; Zhai Li; Gongxin Liu; Vivek Nadkarni; Kyung Ko; William A Coetzee; Edward Y Skolnik
Journal:  Mol Biol Cell       Date:  2005-10-26       Impact factor: 4.138

7.  Systems genetic analysis of brown adipose tissue function.

Authors:  Michal Pravenec; Laura M Saba; Václav Zídek; Vladimír Landa; Petr Mlejnek; Jan Šilhavý; Miroslava Šimáková; Hynek Strnad; Jaroslava Trnovská; Vojtěch Škop; Martina Hüttl; Irena Marková; Olena Oliyarnyk; Hana Malínská; Ludmila Kazdová; Harry Smith; Boris Tabakoff
Journal:  Physiol Genomics       Date:  2017-11-10       Impact factor: 3.107

8.  Plentiful PtdIns5P from scanty PtdIns(3,5)P2 or from ample PtdIns? PIKfyve-dependent models: Evidence and speculation (response to: DOI 10.1002/bies.201300012).

Authors:  Assia Shisheva; Diego Sbrissa; Ognian Ikonomov
Journal:  Bioessays       Date:  2014-11-18       Impact factor: 4.345

Review 9.  Trafficking of intermediate (KCa3.1) and small (KCa2.x) conductance, Ca(2+)-activated K(+) channels: a novel target for medicinal chemistry efforts?

Authors:  Corina M Balut; Kirk L Hamilton; Daniel C Devor
Journal:  ChemMedChem       Date:  2012-08-07       Impact factor: 3.466

10.  Role of the K(Ca)3.1 K+ channel in auricular lymph node CD4+ T-lymphocyte function of the delayed-type hypersensitivity model.

Authors:  Susumu Ohya; Erina Nakamura; Sayuri Horiba; Hiroaki Kito; Miki Matsui; Hisao Yamamura; Yuji Imaizumi
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.